| A central role for LRRK2 in idiopathic Parkinson Disease R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... Science translational medicine 10 (451), 2018 | 11 | 2018 |
| A Potential Cluster Near Site of Dry Cleaning Contamination M Pawlik, S Lettenberger, M Zafar, M Coffey, A Sarkar, P Auinger, ... MOVEMENT DISORDERS 37, S25-S25, 2022 | | 2022 |
| Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease EM Rocha, B De Miranda, LH Sanders Neurobiology of disease 109, 249-257, 2018 | 690 | 2018 |
| Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease BR De Miranda, EM Rocha, Q Bai, A El Ayadi, D Hinkle, EA Burton, ... Neurobiology of disease 115, 101-114, 2018 | 100 | 2018 |
| Dopaminergic neurotoxicants cause biphasic inhibition of purinergic calcium signaling in astrocytes KM Streifel, AL Gonzales, B De Miranda, R Mouneimne, S Earley, ... PLoS One 9 (11), e110996, 2014 | 13 | 2014 |
| Dry Cleaning & Parkinson’s Disease: Evaluation of a Potential Cluster (P11-11.001) M Pawlik, M Zafar, S Lettenberger, M Coffey, A Sarkar, C Tanner, ... Neurology 98 (18_supplement), 859, 2022 | | 2022 |
| Dry‐Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation ER Dorsey, D Kinel, ME Pawlik, M Zafar, SE Lettenberger, M Coffey, ... Movement Disorders 39 (3), 606-613, 2024 | 1 | 2024 |
| Etiology and Pathogenesis of Parkinson’s BR de Miranda, JT Greenamyre | | 2017 |
| Etiology and pathogenesis of Parkinson’s disease BR de Miranda, JT Greenamyre | 15 | 2017 |
| Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration A Zharikov, Q Bai, BR De Miranda, A Van Laar, JT Greenamyre, ... Neurobiology of disease 125, 146-153, 2019 | 44 | 2019 |
| Low-dose inhalation exposure to trichloroethylene induces dopaminergic neurodegeneration in rodents A Adamson, N Ilieva, WJ Stone, BR De Miranda Toxicological Sciences 196 (2), 218-228, 2023 | 5 | 2023 |
| Low‐dose 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor‐κB reporter mice prior to loss of dopaminergic neurons JA Miller, BR Trout, KA Sullivan, RA Bialecki, RA Roberts, RB Tjalkens Journal of neuroscience research 89 (3), 406-417, 2011 | 26 | 2011 |
| LRRK2 activation in idiopathic Parkinson’s disease R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... Science translational medicine 10 (451), eaar5429, 2018 | 450 | 2018 |
| LRRK2 activation in idiopathic Parkinson’s disease. Sci Transl Med 10: eaar5429 R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... | 19 | 2018 |
| LRRK2 and idiopathic Parkinson’s disease EM Rocha, MT Keeney, R Di Maio, BR De Miranda, JT Greenamyre Trends in neurosciences 45 (3), 224-236, 2022 | 80 | 2022 |
| LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease EM Rocha, BR De Miranda, S Castro, R Drolet, NG Hatcher, L Yao, ... Neurobiology of disease 134, 104626, 2020 | 81 | 2020 |
| LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants NM Ilieva, EK Hoffman, MA Ghalib, JT Greenamyre, BR De Miranda Neurobiology of Disease 196, 106522, 2024 | | 2024 |
| Molecular regulation of glial inflammation in Parkinson's disease BR De Miranda, R Tjalkens, T Kato, M Legare, D Mykles Colorado State University. Libraries, 2014 | | 2014 |
| Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson’s disease BR De Miranda, JA Miller, RJ Hansen, PJ Lunghofer, S Safe, ... Journal of Pharmacology and Experimental Therapeutics 345 (1), 125-138, 2013 | 69 | 2013 |
| Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease BR De Miranda, KA Popichak, SL Hammond, JA Miller, S Safe, ... Toxicological Sciences 143 (2), 360-373, 2015 | 59 | 2015 |
